Vol 10, Supplement 35 (December 30, 2018): Journal of Thoracic Disease (Onco-Cardiology)

Review Article

Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity
Lars Michel, Tienush Rassaf, Matthias Totzeck
Cardiovascular adverse events in multiple myeloma patients
Markus B. Heckmann, Shirin Doroudgar, Hugo A. Katus, Lorenz H. Lehmann
The breast cancer patient in the cardioncology unit
Daniela Cardinale, Vincenzo Caruso, Carlo M. Cipolla
Heart failure in cancer: role of checkpoint inhibitors
Murilo Delgobo, Stefan Frantz
Molecular mechanisms underlying cardiotoxicity of novel cancer therapeutics
Simon Braumann, Stephan Baldus, Roman Pfister
Cardio-toxicity in childhood cancer survivors “Cure is not enough”
Ulrich Neudorf, Anne Schönecker, Dirk Reinhardt
Cardiovascular imaging in cardio-oncology
Amir Abbas Mahabadi, Christoph Rischpler
Arterial events in cancer patients—the case of acute coronary thrombosis
Ohad Oren, Joerg Herrmann
Modern concepts in cardio-oncology
Tienush Rassaf, Matthias Totzeck
Exercise training in cancer related cardiomyopathy
Julian G. Westphal, P. Christian Schulze
Cardio-toxicity of checkpoint inhibitors
Oliver J. Müller, Martina E. Spehlmann, Norbert Frey


The supplement “Onco-Cardiology” was commissioned by the Editorial office, Journal of Thoracic Disease without any sponsorship or funding. Tienush Rassaf served as the unpaid Guest Editor for the supplement.